MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NPS Pharmaceuticals Company Profile (NASDAQ:NPSP)

Consensus Ratings for NPS Pharmaceuticals (NASDAQ:NPSP) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for NPS Pharmaceuticals (NASDAQ:NPSP)
Show:
DateFirmActionRatingPrice TargetActions
1/14/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$42.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015BarclaysDowngradeOverweight -> Equal Weight$50.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015CRT CapitalDowngradeBuy -> Fair ValueView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015Jefferies GroupSet Price TargetHold$26.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015WedbushDowngradeOutperform -> Neutral$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015Canaccord GenuityDowngradeBuy -> Hold$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Sterne Agee CRTInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2014Goldman SachsDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2014FBR & Co.Boost Price TargetOutperform$34.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2014Janney Montgomery ScottInitiated CoverageBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Leerink SwannReiterated RatingOutperform$47.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014OppenheimerLower Price TargetOutperform$44.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 4/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha